Sign up to save your podcasts
Or
Share Targeted Talks
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Targeted Talks
Targeted Talks episodes
- S2 Ep6: Special Episode: Insight on Targeting Rare Genomic Alterations in Colorectal CancerIn season 2, episode 6 of Targeted Talks, Dr. Michael J. Overman joins us for a special discussion around rare genomic alterations in colorectal cancer.17 min
- S2 Ep5: Advancing the Treatment of Cervical and Endometrial CancersIn season 2, episode 6 of Targeted Talks, Alexander B. Olawaiye, MD leads a discussion with Haider S. Mahdi, MD, about the modern approaches to treating cervical and endometrial cancers.34 min
- S2 Ep4: Special Episode: Oncology After COVID-19In season 2, episode 4 of Targeted Talks, Benjamin O. Anderson, MD, FACS, discussed the lessons learned from the COVID-19 pandemic, and preparation for a post-COVID America.9 min
- S2 Ep3: Modern Strategies Improving Immunotherapy in CancerJason Luke, MD, leads a discussion with Sandip Patel, MD, about the present and future of immunotherapy in cancer.30 min
- S2 Ep2: The Impact of the Gut Microbiome in Young Patients With Colorectal CancerCathy Eng, MD and Benjamin Weinberg, MD discuss the gut microbiome and how it impacts young patients with colorectal. They also discuss the potential to use gut microbiome test to inform diagnosis, treatment, and monitoring of patients.33 min
- S2 Ep1: Therapies on the Horizon in EGFR Exon 20–Positive Lung CancerNagashree Seetharamu, MD and with Luis E. Raez, MD discuss the evolving treatment landscape of EGFR exon 20–mutated lung cancer.29 min
- S1 Ep5: COVID-19 Leaves Its Mark on Oncology CareDebra Patt, MD, PhD, MBA, speaks with Alex Spira, MD, PhD, FACP, about the impact of the COVID-19 pandemic on community cancer centers and hospitals in the United States27 min
- S1 Ep4: Prostate Cancer Sees Surge of PARP Inhibition StrategiesIn season 1, episode 4 of Targeted Talks, Michael Schweizer, MD, associate professor. Clinical Research Division, Fred Hutchinson Cancer Research Center, spoke with fellow oncologist, Winston Tan, MD, medical oncologist and professor of medicine, Mayo Clinic, about the ever-changing treatment landscape for prostate cancer.25 min
- S1 Ep3: Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts DiscussIn season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion with Stephanie Graff, MD, and Gabriel N. Hortobagyi, MD, FACP.29 min
- S1 Ep2: Precision Medicine Guiding Ovarian Cancer TreatmentSarah M. Temkin, MD leads a discussion with Daphne B. Stewart, MD, around targeted therapies in ovarian cancer, whether offered in the academic or community setting.39 min
About Targeted Talks
From the publisher's feed
Targeted Talks is a podcast series from Targeted Oncology featuring one-on-one conversations with leading oncologists about the issues shaping cancer care today. Each episode explores the real-world challenges clinicians face alongside discussions of emerging research across tumor types. Whether unpacking new data, translating conference highlights into clinical context, or addressing the practical realities of oncology practice, Targeted Talks delivers timely, actionable conversations designed for today's oncology professionals.
For more visit: https://www.targetedonc.com/podcasts
More shows like Targeted Talks
Planet Money
30,577 Listeners
Interesting Times
7,114 Listeners